AstraZeneca plc (NYSE: AZN)
|
|
---|---|
Pricing data not available |
Open: | $ n/a | Volume: | n/a | |
---|---|---|---|---|
High: | $ n/a | Yield(%) | n/a | |
Low: | $ n/a | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | n/a | |
EPS ($) | n/a | Shares Out: | n/a |
% Price Change (last 4 weeks): | -2.44 |
---|---|
% Price Change (last 13 weeks): | -3.00 |
% Price Change (last 26 weeks): | 0.70 |
% Price Change (last 52 weeks): | 20.77 |
% Price Change (year to date): | 12.86 |
Return on Equity (%): | 15.63 |
---|---|
Return on Assets (%): | 6.03 |
Return on Invested Capital (%): | 5.93 |
Gross Profit Margin (%): | 73.95 |
---|---|
Net Profit Margin (%): | 13.00 |
Operating Profit Margin (%): | 20.54 |
50-day Moving Average: | $80.17 |
---|---|
200-day Moving Average: | $74.71 |
Avg. Daily Vol. (last 50 days): | 3,892,531 |
Avg. Daily Vol. (last 200 days): | 4,993,152 |
52-wk high: | $n/a |
52-wk low: | $n/a |
Bid: | $n/a |
Ask: | $n/a |
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
|
AstraZeneca plc
Cambridge Biomedical Campus 1 Francis Crick Avenue Cambridge CA CB2 0AA Phone: 44.20.3749.5000 Fax: n/a http://www.astrazeneca.co.uk |
Earnings (1year) ($): | 2.08 |
---|---|
Annual Dividend ($): | 1.42 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 12.63 |
Cash Flow ($): | 3.51 |
Price/Earnings (x): | 36.11 |
---|---|
Price/Sales (x): | 4.59 |
Price/Book (x): | 5.33 |
Price/Cash Flow (x): | 19.79 |
Quick Ratio (x): | 0.64 |
---|---|
Current Ratio (x): | 0.82 |
LT Debt/Equity (x): | 59.33 |
Total Debt/Equity (x): | 73.12 |